Company intelligence / Profile preview
Lead Discovery Siena
Siena, Toscana, Italy
- Ownership
- Private
- Development stage
- Other
01
Overview
Lead Discovery Siena excels in early-stage drug discovery, advancing several small molecule and bioconjugate programs for oncology and anti-infective indications, including progression of molecules to pre-clinical milestones as evidenced by patents, publications, and collaborations with academia and industry partners[2][3].
- Therapeutic areas
- OncologyInfectious DiseasesRare DiseasesPulmonology
- Modalities
- Small moleculeAntibody-drug conjugatePeptidesProtein
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Novartis Oncology (BioInItaly Forum award partner)[2]Toscana Life Sciences incubator[2][3]
Beyond the preview
Go deeper on Lead Discovery Siena.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lead Discovery Siena.